Where is Interius headquartered?

Interius is located in Philadelphia, PA.

Who invested in Interius?

Interius has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Interius?

Interius closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

interiusbio.com

Interius

Interius is a Pennsylvania-based biotechnology firm that researches and develops T-cell gene therapies for the treatment of malignant hematological tumors.

Business Model:

Revenue: $3M

Employees: 11-50

Geographic Data

Address: 3401 Grays Ferry Avenue

City: Philadelphia

State: PA

Zip: 19146

Country: US

Financial Info

Stage:

series a

Raised Last:

$76M

Raised Total:

$78M

Social

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Interius is a Pennsylvania-based biotechnology firm that researches and develops T-cell gene therapies for the treatment of malignant hematological tumors.

Contact Phone:
+16106394644

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2020	Venture Round		$0	Agent Capital Bruce A. Peacock Penn Medicine Co-Investment Program Tellus BioVentures The Mark Foundation for Cancer Research Agent Capital Bruce A. Peacock Penn Medicine Co-Investment Program Tellus BioVentures The Mark Foundation for Cancer Research
4/2021	Series A		$1.6M	Tellus Bioventures Penn Medicine Agent Capital The Mark Foundation For Cancer Research
5/2021	Series A		$0	Agent Capital Bain Capital Life Sciences BrightEdge Fund Cormorant Asset Management Fairmount Funds Management Knollwood Investment Advisory Logos Capital Longwood Fund OUP (Osage University Partners) Penn Medicine Co-Investment Program Pfizer Venture Investments Quan Capital RA Capital Management Tellus BioVentures The Mark Foundation for Cancer Research University of Pennsylvania Agent Capital Bain Capital Life Sciences BrightEdge Fund Cormorant Asset Management Fairmount Funds Management Knollwood Investment Advisory Logos Capital Longwood Fund OUP (Osage University Partners) Penn Medicine Co-Investment Program Pfizer Venture Investments Quan Capital RA Capital Management Tellus BioVentures The Mark Foundation for Cancer Research University of Pennsylvania
5/2021	Series A	16	$76M	Cormorant Asset Management Fairmount Funds Bain Capital Life Sciences RA Capital Management Longwood Fund Logos Capital Osage University Partners Quan Capital Tellus BioVentures the University of Pennsylvania and Penn Medicine Agent Capital the Mark Foundation for Cancer Research BrightEdge Agent Capital Bain Capital Life Sciences BrightEdge Fund Cormorant Asset Management Fairmount Funds Management Knollwood Investment Advisory Logos Capital Longwood Fund OUP (Osage University Partners) Penn Medicine Co-Investment Program Pfizer Venture Investments Quan Capital RA Capital Management Tellus BioVentures The Mark Foundation for Cancer Research University of Pennsylvania
3/2020	Venture Round	5	$5.5M	Agent Capital Bruce A. Peacock Penn Medicine Co-Investment Program Tellus BioVentures The Mark Foundation for Cancer Research Agent Capital Bruce A. Peacock Penn Medicine Co-Investment Program Tellus BioVentures The Mark Foundation for Cancer Research

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details